




Instance: composition-en-e96a2b015f0fafafc915826cda7b875c
InstanceOf: CompositionUvEpi
Title: "Composition for dificlir Package Leaflet"
Description:  "Composition for dificlir Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/11/733/003-004"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpe96a2b015f0fafafc915826cda7b875c)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - dificlir"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What DIFICLIR is and what it is used for </li>
<li>What you need to know before you take DIFICLIR </li>
<li>How to take DIFICLIR </li>
<li>Possible side effects </li>
<li>How to store DIFICLIR </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What dificlir is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What dificlir is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>DIFICLIR is an antibiotic which contains the active substance fidaxomicin. </p>
<p>DIFICLIR film-coated tablets are used in adults, adolescents and children with a body weight of at 
least 12.5 kg to treat infections of the lining of the colon (large intestine) with certain bacteria called 
Clostridioides difficile. This serious illness can result in painful, severe diarrhoea. DIFICLIR works by 
killing the bacteria that cause the infection and helps to reduce the associated diarrhoea.  </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take dificlir"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take dificlir"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take DIFICLIR </p>
<p>If you are allergic to fidaxomicin or any of the other ingredients of this medicine (listed in 
section 6).  </p>
<p>Warnings and precautions 
Talk to your doctor or pharmacist before taking DIFICLIR. </p>
<p>If you feel that you might have a severe allergic reaction such as trouble breathing (dyspnea), swelling 
of the face or throat (angioedema), severe rash, severe itching (pruritus) or severe hives (urticaria), 
stop taking DIFICLIR and seek medical advice urgently from your doctor, pharmacist or at your local 
hospital emergency department (see section 4). </p>
<p>If you are allergic to macrolides (a class of antibiotics), ask your doctor for advice before using this 
medicine. Your doctor will tell you whether this medicine is suitable for you. </p>
<p>If you have kidney or liver problems, ask your doctor for advice before using this medicine. Your 
doctor will tell you whether this medicine is suitable for you. </p>
<p>There are limited data available on the use of fidaxomicin in severe cases of the disease (e.g. 
pseudomembranous colitis). Your doctor will know whether your disease falls in the severe categories 
and will tell you whether this medicine is suitable for you. </p>
<p>Children and adolescents 
Do not give this medicine to children with a body weight below 12.5 kg, because these children 
require a reduced dose. For appropriate dosing in these patients, DIFICLIR granules for oral 
suspension may be used. </p>
<p>Other medicines and DIFICLIR 
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. </p>
<p>DIFICLIR blood levels can be affected by other medicines you take, and blood levels of other 
medicines can be affected by taking DIFICLIR. Examples of such medicines are: </p>
<p>cyclosporin (a medicine used to dampen down the body s immune reactions, used e.g. after an 
organ or bone marrow transplant, for psoriasis or eczema, or for rheumatoid arthritis or 
nephrotic syndrome) </p>
<p>ketoconazole (a medicine used to treat fungal infections) </p>
<p>erythromycin (a medicine used to treat ear, nose, throat, chest and skin infections) </p>
<p>clarithromycin (a medicine used to treat chest infections, throat and sinus infections, skin and 
tissue infections and Helicobacter pylori infections associated with duodenal or stomach ulcer) </p>
<p>verapamil (a medicine used to treat high blood pressure or to prevent chest pain attacks, or used 
following a heart attack to prevent another one) </p>
<p>dronedarone and amiodarone (medicines used to control the heartbeat) </p>
<p>dabigatran etexilat (a medicine used to prevent the formation of blood clots after hip or knee 
replacement surgery)<br />
You should not use DIFICLIR in combination with one of these medicines, unless your doctor tells 
you otherwise. If you use one of these medicines, please ask your doctor for advice before taking this 
medicine. </p>
<p>Pregnancy and breast-feeding 
You should not take DIFICLIR if you are pregnant, unless your doctor tells you otherwise.<br />
This is because it is not known whether fidaxomicin can harm your baby.<br />
If you are pregnant or think you may be pregnant, ask your doctor or pharmacist for advice before 
taking this medicine. </p>
<p>It is not known whether fidaxomicin passes into breast milk, but it is not expected to do so. 
If you are breastfeeding ask your doctor or pharmacist for advice before taking this medicine. </p>
<p>Driving and using machines 
DIFICLIR is not expected to affect your ability to drive, use tools or machines. </p>
<p>DIFICLIR contains sodium 
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially  sodium-
free . </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take dificlir"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take dificlir"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor or pharmacist has told you. You should check with 
your doctor or pharmacist if you are not sure. </p>
<p>The standard dosing for patients weighing at least 12.5 kg is one tablet (200 mg) twice daily (one 
tablet every 12 hours) for 10 days (see scheme 1 below). </p>
<p>It is possible that your doctor has prescribed an alternate dosing. The recommendation for an alternate 
dosing is twice daily administration for days 1-5. Do not take a tablet on day 6, then once daily every 
other day for the days 7-25 (see also scheme 2 below). </p>
<p>Scheme 1 - Standard dosing 
DAY 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Morning 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
Evening 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg </p>
<p>Scheme 2 - Alternate dosing 
200 mg - Dificlir 200 mg film-coated tablet 
-      No tablet </p>
<p>Swallow the tablets whole with a glass of water. You can take DIFICLIR before, during or after meals. </p>
<p>DIFICLIR granules for oral suspension should be used for patients with a body weight of less than 
12.5 kg. This form of this medicine (oral suspension) may also be more suitable for patients above 
12.5 kg; ask your doctor or pharmacist. </p>
<p>If you take more DIFICLIR than you should 
If you have taken more tablets than you should have, talk to a doctor. Take the medicine pack with 
you so the doctor knows what you have taken. </p>
<p>If you forget to take DIFICLIR 
Take the tablet as soon as you remember, unless it is time for the next dose. In that case, skip the 
missed dose. Do not take a double dose to make up for a forgotten dose. </p>
<p>If you stop taking DIFICLIR 
Do not stop taking DIFICLIR, unless your doctor has advised you to do so. 
Keep taking this medicine until the course is finished, even if you feel better. 
If you stop taking this medicine too soon, the infection may come back. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>A severe allergic reaction may occur, including trouble breathing (dyspnea), swelling of the face or 
throat (angioedema), severe rash or severe itching (pruritus) (see section 2). If such reaction occurs, 
stop taking DIFICLIR and seek medical advice urgently from your doctor, pharmacist or at your local 
hospital emergency department. </p>
<p>The most common side effects (may affect up to 1 in 10 people) are: </p>
<p>vomiting </p>
<p>nausea </p>
<p>constipation. </p>
<p>DAY 
1 
2 
3 
4 
5 
Morning 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
Evening 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
DAY 
6 
7 
8 
9 
- 200 mg 
- 200 mg 
- 200 mg 
- 200 mg 
- 200 mg 
DAY 
- 200 mg 
- 200 mg 
- 200 mg 
- 200 mg 
- 200 mg 
Other possible side effects are the following: 
Uncommon side effects (may affect up to 1 in 100 people) </p>
<p>decreased appetite </p>
<p>dizziness, headache </p>
<p>dry mouth, altered taste (dysgeusia) </p>
<p>bloated feeling, wind (flatulence) </p>
<p>rash, itching (pruritus) </p>
<p>Not known side effects (frequency cannot be estimated from the available data) 
  swelling of the face and throat (angioedema), trouble breathing (dyspnea) </p>
<p>Additional side effects in children and adolescents </p>
<p>hives </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store dificlir"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store dificlir"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton after  EXP . The expiry 
date refers to the last day of that month. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help to protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What DIFICLIR contains  </p>
<p>The active substance is fidaxomicin. Each film-coated tablet contains 200 mg of fidaxomicin.  </p>
<p>The other ingredients are: 
Tablet core: microcrystalline cellulose, pregelatinised starch, hydroxypropyl cellulose, butylated 
hydroxytoluene, sodium starch glycolate and magnesium stearate 
Coating: polyvinyl alcohol, titanium dioxide (E171), talc, polyethylene glycol and lecithin (soy) </p>
<p>What DIFICLIR looks like and contents of the pack 
DIFICLIR 200 mg film-coated tablets are capsule shaped tablets, white to off-white in colour, with 
 FDX  on one side and  200  on the other side. </p>
<p>DIFICLIR is available in: 
100 x 1 film-coated tablet in alu/alu perforated unit dose blisters. 
20 x 1 film-coated tablet in alu/alu perforated unit dose blisters. </p>
<p>DIFICLIR is also available in the form of granules for oral suspension. </p>
<p>Not all pack sizes may be marketed. </p>
<p>Marketing Authorisation Holder and Manufacturer 
Tillotts Pharma GmbH 
Warmbacher Strasse 79618 Rheinfelden 
Germany </p>
<p>This leaflet was last revised in  </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-e96a2b015f0fafafc915826cda7b875c
InstanceOf: CompositionUvEpi
Title: "Composition for dificlir Package Leaflet"
Description:  "Composition for dificlir Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/11/733/003-004"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpe96a2b015f0fafafc915826cda7b875c)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - dificlir"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen 
1. Virkning og anvendelse<br />
2. Det skal De vide, før De begynder at tage DIFICLIR 
3. Sådan skal De tage DIFICLIR 
4. Bivirkninger 
5. Opbevaring 
6. Pakningsstørrelser og yderligere oplysninger </p>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What dificlir is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What dificlir is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>DIFICLIR er et antibiotikum, som indeholder det aktive stof fidaxomicin.  </p>
<p>DIFICLIR filmovertrukne tabletter anvendes til behandling af voksne, unge og børn med en vægt på 
mindst 12,5 kg, der har infektioner i tarmvæggen (tyktarmen) forårsaget af bakterien Clostridioides 
difficile. Denne alvorlige tilstand kan resultere i smertefuld, svær diarré. DIFICLIR virker ved at 
dræbe den bakterie, der er skyld i infektionen, og er med til at mindske den deraf følgende diarré.  </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take dificlir"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take dificlir"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke DIFICLIR 
- hvis De er allergisk over for fidaxomicin eller et af de øvrige indholdsstoffer i dette lægemiddel 
(angivet i punkt 6). </p>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen eller apotekspersonalet, før De tager DIFICLIR. </p>
<p>Hvis De føler, at De måske får en alvorlig allergisk reaktion, såsom åndedrætsbesvær, hævelse af 
ansigt eller svælg (angioødem), alvorligt udslæt, svær kløe eller svær nældefeber, skal De stoppe med 
at tage DIFICLIR og straks kontakte Deres læge eller Deres lokale skadestue (se punkt 4). </p>
<p>Hvis De er overfølsom overfor makrolider (en type af antibiotika), skal De spørge Deres læge til råds, 
inden De tager denne medicin. Deres læge vil fortælle Dem, om denne medicin er den rette behandling 
for Dem.  </p>
<p>Hvis De har nyreproblemer eller leverproblemer, skal De spørge Deres læge til råds, inden De bruger 
denne medicin. Deres læge vil fortælle Dem, om denne medicin er den rette behandling for Dem.  </p>
<p>Den aktuelle viden om brug af fidaxomicin i svære sygdomstilfælde (f.eks. pseudomembranøs kolitis) 
er begrænset. Deres læge vil vide, om Deres sygdom hører til de svære kategorier, og vil fortælle 
Dem, om denne medicin er den rette behandling for Dem.  </p>
<p>Børn og unge 
Giv ikke denne medicin til børn med en vægt under 12,5 kg, da disse børn skal have en reduceret 
dosis. For relevant dosering til disse patienter kan DIFICLIR-granulat til oral suspension anvendes. </p>
<p>Brug af anden medicin sammen med DIFICLIR 
Fortæl altid lægen eller apotekspersonalet, hvis De bruger anden medicin, for nylig har brugt anden 
medicin eller planlægger at bruge anden medicin. </p>
<p>Blodets indhold af DIFICLIR kan påvirkes af anden medicin De tager, og blodets indhold af anden 
medicin kan blive påvirket ved at tage DIFICLIR. Disse lægemidler er blandt andre:</p>
<ul>
<li>ciclosporin (et lægemiddel, der anvendes til at dæmpe kroppens immunforsvar, og som f.eks. 
anvendes efter en organ- eller knoglemarvstransplantation, mod psoriasis eller eksem, eller mod 
leddegigt eller nefrotisk syndrom) </li>
<li>ketoconazol (et lægemiddel, der anvendes til behandling af svampeinfektioner) </li>
<li>erythromycin (et lægemiddel, der anvendes til behandling af infektioner i øre, næse, hals, 
brystkasse og hud) </li>
<li>clarithromycin (et lægemiddel, der anvendes til at behandle infektioner i brystkasse, hals, 
bihuler, hud og væv samt infektioner med Helicobacter pylori i forbindelse med sår på 
tolvfingertarmen eller mavesår) </li>
<li>verapamil (et lægemiddel, der anvendes til behandling af for højt blodtryk eller til at forebygge 
anfald af brystsmerter eller anvendes efter et hjerteanfald for at forebygge et nyt) </li>
<li>dronedaron og amiodaron (lægemidler, der anvendes til at styre hjerterytmen) </li>
<li>dabigatranetexilat (et lægemiddel, der anvendes til at forebygge blodpropper efter operationer til 
udskiftning af hofte eller knæ). 
De bør ikke anvende DIFICLIR i kombination med medicin af denne type, medmindre De har aftalt 
andet med Deres læge. Hvis De tager medicin af denne type, bedes De tale med Deres læge, inden De 
bruger denne medicin.  </li>
</ul>
<p>Graviditet og amning 
De bør ikke tage DIFICLIR, hvis De er gravid, medmindre De har aftalt andet med Deres læge.<br />
Man ved ikke, om fidaxomicin kan skade Deres barn. 
Hvis De er gravid, har mistanke om, at De er gravid, eller planlægger at blive gravid, skal De spørge 
Deres læge eller apotekspersonalet til råds, før De bruger dette lægemiddel.  </p>
<p>Man ved ikke, om fidaxomicin kan passere over i mælk, men det forventes ikke.<br />
Hvis De ammer, skal De spørge Deres læge eller apotekspersonalet til råds, før De bruger dette 
lægemiddel.  </p>
<p>Trafik- og arbejdssikkerhed 
DIFICLIR forventes ikke at påvirke evnen til at føre motorkøretøj eller betjene maskiner. </p>
<p>DIFICLIR indeholder natrium 
Dette lægemiddel indeholder mindre end 1 mmol (23 mg) natrium pr. tablet, dvs. det er i det 
væsentlige natriumfrit. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take dificlir"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take dificlir"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid lægemidlet nøjagtigt efter lægens eller apotekspersonalets anvisning. Er De i tvivl, så spørg 
lægen eller apotekspersonalet. </p>
<p>Standarddoseringen for patienter, der vejer mindst 12,5 kg, er én tablet (200 mg) to gange dagligt (én 
tablet hver 12. time) i 10 dage (se skema 1 nedenfor). </p>
<p>Det er muligt, at Deres læge har ordineret en alternativ dosering, hvor lægemidlet skal tages to gange 
dagligt på dag 1-5. På dag 6 skal lægemidlet ikke tages. Herefter skal lægemidlet tages én gang dagligt 
hver anden dag, på dag 7-25 (se også skema 2 nedenfor). </p>
<p>Skema 1 - Standarddosering 
DAG 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Morgen 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
Aften 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg </p>
<p>Skema 2 - Alternativ dosering </p>
<p>200 mg - Dificlir 200 mg filmovertrukket tablet 
-    Ingen tablet </p>
<p>Tabletterne sluges hele sammen med et helt glas vand. De kan tage DIFICLIR før, under og efter 
måltider. </p>
<p>DIFICLIR-granulat til oral suspension skal anvendes til patienter med en vægt under 12,5 kg. Denne 
form for medicin (oral suspension) kan også være bedre egnet til patienter, der vejer over 12,5 kg; 
spørg lægen eller apotekspersonalet. </p>
<p>Hvis De har taget for meget DIFICLIR 
Hvis De har taget flere tabletter end De burde, så spørg Deres læge til råds. Tag medicinpakningen 
med til lægen, så lægen ved præcis, hvad De har taget. </p>
<p>Hvis De har glemt at tage DIFICLIR 
Tag én tablet, så snart De husker det, medmindre det er tidspunktet for næste dosis. I så fald, skal den 
glemte tablet springes over. De må ikke tage en dobbeltdosis som erstatning for den glemte tablet. </p>
<p>Hvis De holder op med at tage DIFICLIR 
Hold ikke op med at tage DIFICLIR, medmindre Deres læge har givet besked herom.<br />
Bliv ved med at tage medicinen, indtil kuren er færdig, også selvom De har det bedre.<br />
Hvis De holder op med at tage medicinen tidligere end angivet i kuren, kan infektionen vende tilbage.  </p>
<p>Spørg lægen eller apotekspersonalet, hvis der er noget, De er i tvivl om.  </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. </p>
<p>En alvorlig allergisk reaktion kan forekomme, herunder problemer med at trække vejret (dyspnø), 
hævelse af ansigt eller svælg (angioødem), alvorligt udslæt eller svær kløe (pruritus) (se punkt 2). Stop 
med at tage DIFICLIR, hvis en sådan reaktion opstår og kontakt straks Deres læge, apotekspersonalet 
eller Deres lokale skadestue. </p>
<p>DAG 
1 
2 
3 
4 
5 
Morgen 
200 mg 
200 mg<br />
200 mg  200 mg  200 mg<br />
Aften 
200 mg<br />
200 mg<br />
200 mg  200 mg  200 mg<br />
DAG 
6 
7 
8 
9 </p>
<ul>
<li>200 mg  </li>
<li>200 mg  </li>
<li>200 mg  </li>
<li>200 mg  </li>
<li>
<p>200 mg<br />
DAG </p>
</li>
<li>
<p>200 mg  </p>
</li>
<li>200 mg  </li>
<li>200 mg  </li>
<li>200 mg  </li>
<li>200 mg<br />
De mest almindelige bivirkninger (kan forekomme hos op til 1 ud af 10 patienter), er: 
− 
Opkastning 
− 
Kvalme 
− 
Forstoppelse. </li>
</ul>
<p>Af andre mulige bivirkninger kan nævnes: 
Ikke almindelige bivirkninger (kan forekomme hos op til 1 ud af 100 patienter) 
− 
Nedsat appetit 
− 
Svimmelhed, hovedpine 
− 
Mundtørhed, ændret smagssans 
− 
Oppustethed, flatulens 
− 
Udslæt, kløe. </p>
<p>Ikke kendt (kan ikke vurderes ud fra forhåndenværende data) 
− 
Hævelse af ansigt og svælg (angioødem), åndedrætsbesvær. </p>
<p>Hos børn og unge kan endvidere ses følgende bivirkninger: 
− 
Nældefeber. </p>
<p>Indberetning af bivirkninger 
Hvis De oplever bivirkninger, bør De tale med Deres læge eller apotekspersonalet. Dette gælder også 
mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. De eller Deres pårørende kan også 
indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem anført i 
Appendiks V. Ved at indrapportere bivirkninger kan De hjælpe med at fremskaffe mere information 
om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store dificlir"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store dificlir"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn. </p>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på kartonen efter "EXP". Udløbsdatoen er den 
sidste dag i den nævnte måned. </p>
<p>Spørg apotekspersonalet, hvordan De skal bortskaffe medicinrester. Af hensyn til miljøet må De ikke 
smide medicinrester i afløbet, toilettet eller skraldespanden. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>DIFICLIR indeholder:</p>
<ul>
<li>Aktivt stof: fidaxomicin. Hver filmovertrukken tablet indeholder 200 mg fidaxomicin. </li>
<li>Øvrige indholdsstoffer: 
Tablet: Mikrokrystallinsk cellulose, prægelatineret stivelse, hydroxypropylcellulose, butyleret 
hydroxytoluen, natriumstivelseglycolat og magnesiumstearat 
Filmovertræk: Polyvinylalkohol, titandioxid (E171), talcum, polyethylenglycol og lecithin 
(soja) </li>
</ul>
<p>Udseende og pakningsstørrelser 
DIFICLIR 200 mg filmovertrukne tabletter er kapselformede tabletter, hvide til råhvide med "FDX" 
på den ene side og "200" på den anden side. </p>
<p>DIFICLIR fås i: 
100 x 1 filmovertrukken tablet i alu/alu perforerede enkeltdosisblistre. 
20 x 1 filmovertrukken tablet i alu/alu perforerede enkeltdosisblistre. </p>
<p>DIFICLIR fås også som granulat til oral suspension. </p>
<p>Ikke alle pakningsstørrelser er nødvendigvis markedsført.  </p>
<p>Indehaver af markedsføringstilladelsen og fremstiller 
Tillotts Pharma GmbH 
Warmbacher Strasse 79618 Rheinfelden 
Tyskland </p>
<p>Denne indlægsseddel blev senest ændret </p>
<p>De kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside: http://www.ema.europa.eu<br />
Indlægsseddel: Information til brugeren </p>
<p>DIFICLIR 40 mg/ml granulat til oral suspension 
fidaxomicin </p>
<p>Læs denne indlægsseddel grundigt, inden De begynder at tage dette lægemiddel, da den 
indeholder vigtige oplysninger. 
- Gem indlægssedlen. De kan få brug for at læse den igen. 
- Spørg lægen eller apotekspersonalet, hvis der er mere, De vil vide. 
- Lægen har ordineret dette lægemiddel til Dem personligt. Lad derfor være med at give 
medicinen til andre. Det kan være skadeligt for andre, selvom de har de samme symptomer, som 
De har. 
- Kontakt lægen eller apotekspersonalet, hvis De får bivirkninger, herunder bivirkninger, som 
ikke er nævnt i denne indlægsseddel. Se punkt 4. Se den nyeste indlægsseddel på www.indlaegsseddel.dk </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-e96a2b015f0fafafc915826cda7b875c
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for dificlir Package Leaflet for language en"
Description: "ePI document Bundle for dificlir Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-e96a2b015f0fafafc915826cda7b875c"
* entry[0].resource = composition-en-e96a2b015f0fafafc915826cda7b875c

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpe96a2b015f0fafafc915826cda7b875c"
* entry[=].resource = mpe96a2b015f0fafafc915826cda7b875c
                            
                    
Instance: bundlepackageleaflet-da-e96a2b015f0fafafc915826cda7b875c
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for dificlir Package Leaflet for language da"
Description: "ePI document Bundle for dificlir Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-e96a2b015f0fafafc915826cda7b875c"
* entry[0].resource = composition-da-e96a2b015f0fafafc915826cda7b875c

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpe96a2b015f0fafafc915826cda7b875c"
* entry[=].resource = mpe96a2b015f0fafafc915826cda7b875c
                            
                    



Instance: mpe96a2b015f0fafafc915826cda7b875c
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product DIFICLIR 200 mg film-coated tablets"
Description: "DIFICLIR 200 mg film-coated tablets"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/11/733/003-004"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "DIFICLIR 200 mg film-coated tablets"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: e96a2b015f0fafafc915826cda7b875cListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "dificlir"

* status = #current
* mode = #working

* title = "List of all ePIs associated with dificlir"

* subject = Reference(mpe96a2b015f0fafafc915826cda7b875c)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#dificlir "dificlir"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-e96a2b015f0fafafc915826cda7b875c) // dificlir en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-e96a2b015f0fafafc915826cda7b875c) // dificlir da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-e96a2b015f0fafafc915826cda7b875c
InstanceOf: List

* insert e96a2b015f0fafafc915826cda7b875cListRuleset
    